DK
GILD icon

DJE Kapital’s Gilead Sciences GILD Stock Holding History

DJE Kapital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78M Sell
12,734
-150,788
-92% -$19.9M 0.03% 118
2026
Q1 		$22.6M Sell
163,522
-78,401
-32% -$11M 0.5% 40
2025
Q4 		$29.9M Buy
241,923
+101,042
+72% +$12.3M 0.83% 33
2025
Q3 		$15.5M Hold
140,881
– – 0.38% 52
2025
Q2 		$15.5M Buy
140,881
+77,335
+122% +$8.23M 0.38% 52
2025
Q1 		$6.98M Buy
+63,546
New +$6.56M 0.21% 63

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DJE Kapital's GILD Position: Q2 2026 in Review

DJE Kapital reduced its Gilead Sciences (GILD) stake by 92% in Q2 2026, selling an estimated $19.9M and leaving 12,734 shares worth $1.78M. The position accounts for 0.03% of the portfolio, ranked #118.

DJE Kapital first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $29.9M in Q4 2025. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • DJE Kapital held 12,734 shares of Gilead Sciences worth $1.78M as of Q2 2026.
  • DJE Kapital sold 150,788 Gilead Sciences shares in Q2 2026, an estimated $19.9M.
  • Gilead Sciences made up 0.03% of DJE Kapital's portfolio in Q2 2026, its #118 holding.
  • DJE Kapital first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • DJE Kapital's Gilead Sciences position peaked at $29.9M in Q4 2025.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on DJE Kapital's 13F filing for Q2 2026, filed 4 Aug 2026.